Advisory Committee on Interdisciplinary, Community-Based Linkages; Notice of Meeting, 81624-81625 [2010-32560]
Download as PDF
<![CDATA[
81624
Federal Register / Vol. 75, No. 248 / Tuesday, December 28, 2010 / Notices
publishes abstracts of information
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, e-mail
paperwork@hrsa.gov or call the HRSA
Reports Clearance Office on (301) 443–
1129.
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
Proposed Project: The National Health
Service Corps (NHSC) Scholarship
Program Application (OMB No. 0915–
0146)—[Revision]
The National Health Service Corps
(NHSC) Scholarship Program provides
the NHSC with the health professionals
it requires to carry out its mission of
providing primary health care to
populations residing in areas of greatest
need. Under this program, health
professions students are awarded
scholarships in return for service in a
federally designated Health Professional
Shortage Area (HPSA). Students are
supported who are well qualified to
participate in the NHSC Scholarship
Program and who want to assist the
NHSC in its mission, both during and
after their period of obligated service.
The NHSC Scholarship Program forms
are used to collect relevant information
necessary to make award
determinations. Scholars are selected for
these competitive awards based on the
information provided in the application,
forms, and supporting documentation.
Awards are made to applicants who
demonstrate a high potential for
providing quality primary health care
Number of
respondents
Instrument
Responses/
respondent
services in HPSAs. The program forms
include the following: The NHSC
Scholarship Program Application,
Academic and Non-Academic
Evaluation Letters (formerly Letters of
Recommendation), the Authorization to
Release Information, the Verification of
Acceptance/Good Standing Report, the
Receipt of Exceptional Financial Need
Scholarship, the Verification Regarding
Disadvantaged Background and the
Acceptance/Declination Form. Also
included are the Data Collection
Worksheet, which is completed by the
schools of program participants, the
Deferment Request Form, which is
completed by program participants and
the Six-Month Service Obligation
Verification Form, which is completed
by program participants and their sites.
The annual estimate of burden for
applicants is as follows:
Total
responses
Hours per
response
Total burden
hours
NHSC Scholarship Program Application .............................
Evaluation Letters ................................................................
Authorization to Release Information ..................................
Verification of Acceptance/Good Standing Report ..............
Receipt of Exceptional Financial Need Scholarship ............
Verification Regarding Disadvantaged Background ............
Acceptance/Declination Form ..............................................
1,800
1,800
1,800
1,800
100
300
250
1
2
1
1
1
1
1
1,800
3,600
1,800
1,800
100
300
250
2.0
.50
.10
.25
.25
.25
.10
3,600
1,800
180
450
25
75
25
Total ..............................................................................
........................
........................
9,400
........................
6,155
Number of
respondents
Responses/
respondent
The annual estimate of burden for
participants/schools/sites is as follows:
Instrument
Total
responses
Hours per
response
Total burden
hours
Data Collection Worksheet ..................................................
Deferment Request Form ....................................................
Six-Month Service Obligation Verification Form ..................
400
60
700
1
1
2
400
60
1,400
1.0
.25
.50
400
15
700
Total ..............................................................................
........................
........................
1,860
........................
1,115
emcdonald on DSK2BSOYB1PROD with NOTICES
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to
the OMB desk officer for HRSA, either
by e-mail to
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974. Please direct all
correspondence to the ‘‘attention of the
OMB desk officer for HRSA.’’
Dated: December 21, 2010.
Robert Hendricks,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2010–32562 Filed 12–27–10; 8:45 am]
BILLING CODE 4165–15–P
VerDate Mar<15>2010
22:37 Dec 27, 2010
Jkt 223001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Service
Administration
Advisory Committee on
Interdisciplinary, Community-Based
Linkages; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Committee on
Interdisciplinary, Community-Based
Linkages (ACICBL).
Dates and Times: January 27, 2011,
8:30 a.m. to 5 p.m., EST. January 28,
2011, 8:30 a.m. to 4 p.m., EST.
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
Place: Hilton Washington DC/
Rockville Executive Meeting Center,
1750 Rockville Pike, Rockville, MD
20852. Telephone: 301–468–1100.
Status: The meeting will be open to
the public.
Purpose: The members of the ACICBL
will advance the planning required to
develop their 11th Annual Report for
the Secretary of the Department of
Health and Human Services (the
Secretary) and Congress, using the
working topic, Continuing Education,
Professional Development and Lifelong
Learning for the 21st Century Health
Care Workforce. The meeting will
provide the planning and writing subcommittees with the opportunity to
review the urgent issues related to the
E:\FR\FM\28DEN1.SGM
28DEN1
Federal Register / Vol. 75, No. 248 / Tuesday, December 28, 2010 / Notices
training programs, identify resources
that will address the gaps and further
strengthen the outcomes from these
efforts, examine testimony from the
experts in the field, and offer
recommendations for improvement of
these training programs to the Secretary
and the Congress.
Agenda: The ACICBL agenda includes
an overview of the Committee’s general
business activities, an orientation for the
eight newly appointed members,
presentations by and dialogue with
experts, and discussion sessions specific
to the development of recommendations
to be addressed in the 11th Annual
ACICBL Report. Agenda items are
subject to change as dictated by the
priorities of the Committee.
Requests
to make oral comments or to provide
written comments to the ACICBL should
be sent to Dr. Joan Weiss, Designated
Federal Official at the contact
information below. Individuals who
plan to attend the meeting and need
special assistance should notify Dr.
Weiss at least 10 days prior to the
meeting, using the address and phone
number below. Members of the public
will have the opportunity to provide
comments at the meeting.
SUPPLEMENTARY INFORMATION:
FOR FURTHER INFORMATION CONTACT:
Anyone requesting additional details
should contact Dr. Joan Weiss,
Designated Federal Official within the
Bureau of Health Professions, Health
Resources and Services Administration.
Dr. Weiss may be reached by one of the
three following methods: (1) Via written
request to: Dr. Joan Weiss, Designated
Federal Official, Bureau of Health
Professions, Health Resources and
Services Administration, Parklawn
Building, Room 9–36, 5600 Fishers
Lane, Rockville, Maryland 20857; (2) via
telephone at (301) 443–6950; or (3) via
e-mail at jweiss@hrsa.gov. In the
absence of Dr. Weiss, CAPT Norma J.
Hatot, Senior Nurse Consultant, may be
contacted via telephone at (301) 443–
2681 or by e-mail at nhatot@hrsa.gov.
emcdonald on DSK2BSOYB1PROD with NOTICES
Dated: December 21, 2010.
Robert Hendricks,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2010–32560 Filed 12–27–10; 8:45 am]
BILLING CODE 4165–15–P
VerDate Mar<15>2010
22:37 Dec 27, 2010
Jkt 223001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
AGENCY:
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 207 to achieve expeditious
commercialization of results of
Federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
ADDRESSES: Licensing information and
copies of the U.S. patent applications
listed below may be obtained by writing
to the indicated licensing contact at the
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: 301/
496–7057; fax: 301/402–0220. A signed
Confidential Disclosure Agreement will
be required to receive copies of the
patent applications.
SUMMARY:
Hesperetin Therapy for Metabolic
Syndrome and Insulin Resistance
Description of Technology:
Hesperidin is a flavonoid compound
found in citrus fruits. Large
epidemiological studies have linked
increased consumption of flavonoidrich foods, such as citrus, with reduced
cardiovascular morbidity and mortality.
Investigators from the National Center
for Complementary and Alternative
Medicine have demonstrated that
administration of oral hesperidin to
patients with metabolic syndrome
attenuates biomarkers of inflammation
and improves blood vessel relaxation,
lipid cholesterol profiles, and insulin
sensitivity when compared to controls.
Thus, hesperidin and its active aglycone
form, hesperetin, may be effective
agents for the treatment of diabetes,
obesity, metabolic syndrome,
dyslipidemias, and their cardiovascular
complications including hypertension,
atherosclerosis, coronary heart disease,
and stroke. This technology discloses
methods for using a hesperetin
composition to treat metabolic
syndrome and insulin resistance.
Applications: Therapeutics for
metabolic syndrome and insulin
resistance.
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
81625
Development Status: Clinical trial
data available.
Inventors: Michael J. Quon and
Ranganath Muniyappa (NCCAM).
Publications: Manuscript in
preparation.
Patent Status: U.S. Provisional
Application No. 61/369,229 filled 30
July 2010 (HHS Reference No. E–148–
2010/0–US–01).
Licensing Status: Available for
licensing.
Licensing Contact: Tara L. Kirby,
Ph.D.; 301–435–4426;
kirbyt@mail.nih.gov.
Substituted Triazine and Purine
Compounds for the Treatment of
Chagas Disease and African
Trypanosomiasis
Description of Technology: Parasitic
protozoa are responsible for a wide
variety of infections in both humans and
animals. Trypanosomiasis poses health
risks to millions of people across
multiple countries in Africa and North
and South America. Visitors to these
regions, such as business travelers and
tourists, are also at risk for contracting
parasitic diseases. There are two types
of African trypanosomiasis, also known
as sleeping sickness. One type is caused
by the parasite Trypanosoma brucei
gambiense, and the other is caused by
the parasite Trypanosoma brucei
rhodesiensi. If left untreated, African
sleeping sickness results in death.
Chagas disease, caused by Trypanosoma
cruzi (T. cruzi), affects millions of
people in Mexico and South and Central
America. Untreated, Chagas disease
causes decreased life expectancy and
can also result in death.
The subject invention covers novel
triazine and purine compounds that are
inhibitors of key proteases (cruzain and
Rhodesian) of the parasites
Trypanosoma brucei rhodesiensi and
Trypanosoma cruzi, respectively.
Applications: Prophylactic and
therapeutic treatment of African
trypanosomiasis and Chagas disease.
Advantages
• Novel compounds against the
cysteine proteases, cruzain and
rhodesain.
• Compounds possess low nanomolar
inhibitory potential against cruzain and
rhodesain.
Development Status: In vitro and in
vivo data are available upon request and
upon execution of an appropriate
confidentiality agreement.
Inventors: Craig J. Thomas et al.
(NHGRI).
Related Publication: BT Mott et al.
Identification and optimization of
inhibitors of Trypanosomal cysteine
E:\FR\FM\28DEN1.SGM
28DEN1
]]>Agencies
[Federal Register Volume 75, Number 248 (Tuesday, December 28, 2010)]
[Notices]
[Pages 81624-81625]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-32560]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Service Administration
Advisory Committee on Interdisciplinary, Community-Based
Linkages; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), notice is hereby given of the following
meeting:
Name: Advisory Committee on Interdisciplinary, Community-Based
Linkages (ACICBL).
Dates and Times: January 27, 2011, 8:30 a.m. to 5 p.m., EST.
January 28, 2011, 8:30 a.m. to 4 p.m., EST.
Place: Hilton Washington DC/Rockville Executive Meeting Center,
1750 Rockville Pike, Rockville, MD 20852. Telephone: 301-468-1100.
Status: The meeting will be open to the public.
Purpose: The members of the ACICBL will advance the planning
required to develop their 11th Annual Report for the Secretary of the
Department of Health and Human Services (the Secretary) and Congress,
using the working topic, Continuing Education, Professional Development
and Lifelong Learning for the 21st Century Health Care Workforce. The
meeting will provide the planning and writing sub-committees with the
opportunity to review the urgent issues related to the
[[Page 81625]]
training programs, identify resources that will address the gaps and
further strengthen the outcomes from these efforts, examine testimony
from the experts in the field, and offer recommendations for
improvement of these training programs to the Secretary and the
Congress.
Agenda: The ACICBL agenda includes an overview of the Committee's
general business activities, an orientation for the eight newly
appointed members, presentations by and dialogue with experts, and
discussion sessions specific to the development of recommendations to
be addressed in the 11th Annual ACICBL Report. Agenda items are subject
to change as dictated by the priorities of the Committee.
SUPPLEMENTARY INFORMATION: Requests to make oral comments or to provide
written comments to the ACICBL should be sent to Dr. Joan Weiss,
Designated Federal Official at the contact information below.
Individuals who plan to attend the meeting and need special assistance
should notify Dr. Weiss at least 10 days prior to the meeting, using
the address and phone number below. Members of the public will have the
opportunity to provide comments at the meeting.
FOR FURTHER INFORMATION CONTACT: Anyone requesting additional details
should contact Dr. Joan Weiss, Designated Federal Official within the
Bureau of Health Professions, Health Resources and Services
Administration. Dr. Weiss may be reached by one of the three following
methods: (1) Via written request to: Dr. Joan Weiss, Designated Federal
Official, Bureau of Health Professions, Health Resources and Services
Administration, Parklawn Building, Room 9-36, 5600 Fishers Lane,
Rockville, Maryland 20857; (2) via telephone at (301) 443-6950; or (3)
via e-mail at jweiss@hrsa.gov. In the absence of Dr. Weiss, CAPT Norma
J. Hatot, Senior Nurse Consultant, may be contacted via telephone at
(301) 443-2681 or by e-mail at nhatot@hrsa.gov.
Dated: December 21, 2010.
Robert Hendricks,
Director, Division of Policy and Information Coordination.
[FR Doc. 2010-32560 Filed 12-27-10; 8:45 am]
BILLING CODE 4165-15-P
